Canagliflozin approved for type 2 diabetes

Am J Health Syst Pharm. 2013 May 15;70(10):834. doi: 10.2146/news130035.
No abstract available

Publication types

  • News

MeSH terms

  • Canagliflozin
  • Clinical Trials as Topic
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Drug Approval
  • Glucosides / administration & dosage
  • Glucosides / adverse effects
  • Glucosides / therapeutic use*
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use*
  • Thiophenes / administration & dosage
  • Thiophenes / adverse effects
  • Thiophenes / therapeutic use*
  • United States
  • United States Food and Drug Administration

Substances

  • Glucosides
  • Hypoglycemic Agents
  • Thiophenes
  • Canagliflozin